Cardiac, Thoracic, and Vascular: Heart Flashcards

1
Q

Heart: Anatomy

A
  • Coronary circulation begins at the sinus of Valsalva,

where the right and left coronary arteries (RCA, LCA)

arise. The left main artery branches into the left anterior

descending and the left circumflex arteries. The left

anterior descending artery supplies the anterior of the

left ventricle, the apex of the heart, the intraventricular

septum, and the portion of the right ventricle that bor-

ders the intraventricular septum (Fig. 17-1). The left

circumflex artery travels in the groove separating the

left atrium and ventricle and gives off marginal

branches to the left ventricle. The RCA travels between

the right atrium and ventricle to supply the lateral

portion of the right ventricle (Fig. 17-2). The posterior

descending artery (PDA) comes from the RCA in 90%

of patients and supplies the arteriovenous node.

Patients whose PDA arises from the RCA are termed

right dominant. If the PDA arises from the left circum-

flex, the system is left dominant.

The aortic valve is located between the left ventricle

and the aorta. It usually has three leaflets, which form

three sinuses. One sinus gives rise to the RCA, another

to the LCA, and the third forms the noncoronary sinus.

The mitral valve is located between the left atrium and

ventricle. It normally has two leaflets, with the anterior

protruding farther across the valve. Chordae tendineae

attach the leaflets to the papillary muscles, which in

turn serve to tether the leaflets to the ventricular wall.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Congenital Heart Disease (Part 1)

A
  • Approximately 0.6% of live births will be compli-

cated by congenital heart defects. This risk more than

doubles in subsequent siblings. Most cases are sporadic,

although there are well-known associations of genetic

syndromes and congenital heart defects. These include

atrioventricular canal defects in children with Down

syndrome, coarctation of the aorta in children with

Turner’s syndrome, and supravalvular aortic stenosis

in children with William’s syndrome.

Congenital heart defects are best understood by

the pathophysiology they cause, either congestive

heart failure or cyanosis. Most anomalies fit into one

of these categories.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Congenital Heart Disease (Part 2)

A
  • Congestive heart failure can be caused either by a

left-to-right shunt or an obstructive lesion. Left-

to-right shunts result in a certain fraction of blood

leaving the left side of the heart to the right side,

increasing pulmonary pressure and necessitating large

volume of left ventricular output to satisfy peripheral

demands. Among these lesions are patent ductus arte-

riosus, in which the normal fetal connection between

the pulmonary artery and aorta is not obliterated at

birth. Depending on the size of the communication,

it can cause severe failure. Premature infants with

pulmonary compromise and/or children with an audi-

ble murmur should undergo closure , which can be achieved via catheter-based therapies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Congenital Heart Disease (Part 3)

A
  • Atrial and ventricular septal defects also result in left-

to-right shunting. Patients with atrial septal defects clas-

sically have a second heart sound in which the split is

of fixed duration. Over time such patients can develop

pulmonary hypertension, right and left ventricular fail-

ure, and atrial arrhythmias. Most atrial septal defects

can be closed using percutaneous methods. Ventricular

septal defects may present in a similar fashion with pul-

monary hypertension and congestive heart failure, cul-

minating in Eisenmenger syndrome when the shunt

reverses to a right-to-left shunt, causing cyanosis. These

lesions should be fixed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Congenital Heart Disease (Part 4)

A
  • Atrioventricular canal defects are complicated lesions

involving the atrial and ventricular septae and the

atrioventricular valves. When diagnosed, these lesions

should be fixed. In its extreme form, a single arterial

trunk arises from a joined ventricular chamber; this is

termed a truncus arteriosus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Congenital Heart Disease (Part 5)

A
  • Obstructive lesions can also cause congestive heart
    failure. Aortic stenosis most commonly occurs as a

result of a bicuspid aortic valve, but can also occur at

the supravalvular or subvalvular location, or as a result

of subvalvular ventricular hypertrophy, termed

hypertrophic muscular subaortic stenosis. Although

many procedures may be used to treat this condition,

of particular interest is the Ross operation, which

involves transposing the pulmonary valve to the aortic

position and using a prosthetic graft for a new pul-

monary valve.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Congenital Heart Disease (Part 6)

A
  • Mitral stenosis commonly occurs in association

with other congenital heart defects. Pulmonic stenosis

is often mildly symptomatic and is generally treated

with percutaneous methods. The most common obstructive

lesion in children is coarctation of the aorta. This occurs when the aorta becomes narrowed, usually just

after the takeoff of the left subclavian artery (Fig. 17-3). Often, blood flow to the lower extremities will depend on a patent ductus arteriosus, closure of which can cause

severe heart failure. Because of the risk of endocarditis,

severe hypertension, congestive heart failure, and stroke,

these lesions are repaired.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Congenital Heart Disease (Part 7)

A
  • Right-to-left shunts occur when deoxygenated

blood makes its way into the peripheral circulation;

this is also referred to as cyanotic heart disease. The most

common cause is Tetralogy of Fallot (Fig. 17-4). This

abnormality has four components: ventricular septal

defect, pulmonic stenosis, right ventricular hypertro-

phy, and an overriding aorta.

  • Tricuspid atresia prevents flow from the right atrium

to the right ventricle, and instead, deoxygenated blood

traverses an atrial septal defect into the left atrium.

Other lesions that can cause a right-to-left shunt include

pulmonic atresia, transposition of the great arteries, and

total anomalous pulmonary venous connection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Coronary Artery Disease: Epidemiology

A
  • Atherosclerosis of the coronary arteries is the most

common cause of mortality in the United States,

responsible for one third of all deaths. Approximately

5 million Americans have coronary artery disease,

which is five times more prevalent in men than in

women. Risk factors include hypertension, family his-

tory, hypercholesterolemia, smoking, obesity, dia-

betes, and physical inactivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Coronary Artery Disease: Pathophysiology

A
  • Coronary artery stenosis is a gradual process that begins

in the second decade. When the lumen decreases to

75% of the native area, the lesion becomes hemody-

namically significant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Coronary Artery Disease: History

A
  • Patients with ischemic heart disease usually complain

of substernal chest pain or pressure that may radiate

down the arms or into the jaw, teeth, or back. Typically,

the pain occurs during periods of physical exertion or

emotional stress. Episodes that are reproducible and

resolve with rest are termed stable angina. If the pain

occurs at rest or does not improve with rest, is new and

severe, or is progressive, it is termed unstable angina

and suggests impending infarction. Presentation can be

variable, with patients complaining of indigestion, nau-

sea, vomiting, diaphoresis, cough, new onset arrhyth-

mia, syncope, and, in older adult patients, confusion or

delirium. Ischemic heart disease can also be asympto-

matic, classically in patients with diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Coronary Artery Disease: Physical Examination

A
  • The patient may have evidence of peripheral vascular

disease, including diminished pulses. Signs of ventric-

ular failure, including cardiomegaly, congestive heart

failure, an S3 or S4, or murmur of mitral regurgita-

tion (MR), may occur.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Coronary Artery Disease: Diagnostic Evaluation

A
  • Electrocardiogram (ECG) may show signs of ischemia

or an old infarct. A chest radiograph may show an

enlarged heart or pulmonary congestion. An exercise

stress test is sensitive in identifying myocardium at risk.

These areas can be localized using nuclear medicine

scans, including thallium imaging. Echocardiography is

extremely useful in evaluating myocardial function and

valvular competence. Angiography is the gold standard

for identifying lesions in the coronary arteries, assessing

their severity, and planning operative intervention.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Coronary Artery Disease: Treatment

A
  • Patients with severe disease of the left main artery or

with severe disease in the three major coronary arteries

have decreased mortality after coronary artery bypass

surgery. Pain is reliably relieved in greater than 85% of patients.
* Surgical options include bypass using the internal mam-

mary arteries or saphenous veins. Internal mammary

bypass is preferred because of higher patency rates.

Percutaneous coronary interventions include bal-

loon angioplasty and stent placement. Despite the

tremendous volume of procedures performed in the

United States, the exact indications for interventions

re not well known. A large study in 2005 in the

New England Journal of Medicine by Hannon et al. demon-

strated that in patients with two or more diseased

vessels, stents were associated with an increased need

for further procedures and increased mortality com-

pared with bypass grafting. Because early mortality

was higher with bypass grafting, care must be indi-

vidualized to the patient.

One common problem with coronary stents is

in-stent restenosis. Benefits of drug-eluting stents, which

elaborate various substances including sirolimus and

paclitaxel, remain unclear.

  • It is important to note that nearly all risk factors

for coronary artery disease are modifiable before and

after an event. Preventive medicine used to aggressively

lower blood pressure and cholesterol, combined with

diet and exercise regimens, is critical.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aortic Stenosis: Etiology

A
  • Aortic stenosis (AS) can present early in life—for exam-

ple, when the valve is unicuspid—but more commonly

occurs in the older population. A congenitally bicuspid

valve usually causes AS by the time the patient reaches

70 years of age. Other causes include rheumatic fever,

which results in commissural fusion and subsequent

calcification, and degenerative stenosis, in which calcifi-

cation occurs in the native valve (see Color Plate 13).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Aortic Stenosis: Pathophysiology

A
  • The initial physiologic response to AS is left ventric-

ular hypertrophy to preserve stroke volume and

cardiac output. Left ventricular hypertrophy and

increasing resistance at the level of the valve result in

decreased cardiac output, pulmonary hypertension,

and myocardial ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Aortic Stenosis: History

A
  • Patients often complain of angina, syncope, and dysp-

nea, with dyspnea being the worst prognostic indicator.

18
Q

Aortic Stenosis: Physical Examination

A
  • A midsystolic ejection murmur, as well as cardiomegaly

and other signs of congestive heart failure, may be

present. Pulsus tardus et parvus, a delayed, diminished

impulse at the carotid, may be apparent.

19
Q

Aortic Stenosis: Diagnostic Evaluation

A
  • Echocardiography or cardiac catheterization reliably

studies the valve. A decrease in the aortic valve area

from the normal 3 or 4 cm to less than 1 cm signifies severe

disease.

20
Q

Aortic Stenosis: Treatment

A
  • Patients who are symptomatic should undergo aortic

valve replacement unless other medical conditions

make it unlikely that the patient could survive the

operation. In asymptomatic individuals, progressive

cardiomegaly is an indication for operation, because

surgical therapy is superior to medical therapy.

21
Q

Aortic Insufficiency: Etiology

A
  • Aortic insufficiency can be caused by rheumatic fever,

connective tissue disorders including Marfan and Ehlers-

Danlos syndromes, endocarditis, aortic dissection, and

trauma

22
Q

Aortic Insufficiency: Pathophysiology

A
  • The incompetent valve causes a decrease in cardiac

output, and left ventricular dilatation occurs. The

larger ventricle is subject to higher wall stress, which

increases myocardial oxygen demand.

23
Q

Aortic Insufficiency: History

A
  • Patients complain of angina or symptoms of systolic

dysfunction.

24
Q

Aortic Insufficiency: Physical Examination

A
  • Typically, there is a crescendo-decrescendo diastolic

murmur and a wide pulse pressure with a water ham-

mer quality. The point of maximal impulse may be

displaced or diffuse.

25
Q

Aortic Insufficiency: Diagnostic Evaluation

A
  • Echocardiography is a sensitive and specific means of

making the diagnosis.

26
Q

Aortic Insufficiency: Treatment

A
  • Symptomatic patients should undergo replacement

surgery if their medical condition allows them to tol-

erate a major procedure.

27
Q

Mitral Stenosis: Etiology

A
  • Mitral stenosis (MS) develops in 40% of patients with

rheumatic heart disease. Rheumatic heart disease occurs

after pharyngitis caused by group A streptococcus. A

likely autoimmune phenomenon causes pancarditis,

resulting in fibrosis of valve leaflets. Histologic find-

ings include Aschoff nodules. MS may also be caused by

malignant carcinoid and systemic lupus erythematosus.

28
Q

Mitral Stenosis: Pathophysiology

A
  • Fibrosis progresses over a period of two or three

decades, causing fusion of the leaflets, which take on

a characteristic “fish mouth” appearance, significantly

impeding blood flow through the valve. Increased left

atrial pressures lead to left atrial hypertrophy, which

in turn may cause atrial fibrillation or pulmonary

hypertension. Pulmonary hypertension can further

progress to right ventricular hypertrophy and right-

sided heart failure.

29
Q

Mitral Stenosis: Epidemiology

A
  • MS has a female predominance of 2:1.
30
Q

Mitral Stenosis: History

A
  • Characteristic complaints include dyspnea and fatiga-
    bility. Occasionally, pulmonary hypertension leads to

hemoptysis.

31
Q

Mitral Stenosis: Physical Examination

A
  • Cachexia or symptoms of congestive heart failure

may be present, with pulmonary rales and tachypnea.

Jugular venous distention, peripheral edema, ascites,

and a sternal heave of right ventricular hypertrophy

may be appreciable. Heart sounds are usually charac-

teristic, consisting of an opening snap followed by a

low rumbling murmur. The splitting of the second

heart sound is decreased, and the pulmonary compo-

nent is louder. The heart rate may demonstrate the

irregular pattern of atrial fibrillation.

32
Q

Mitral Stenosis: Diagnostic Evaluation

A
  • Chest x-ray may show cardiomegaly, including signs of

left atrial hypertrophy. Pulmonary edema may be pres-

ent. ECG may show atrial fibrillation. Broad, notched

P waves are an indication of left atrial hypertrophy.

Right axis deviation is evidence of right ventricular

hypertrophy. Echocardiography with Doppler flow

measurement is extremely useful for demonstrating

MS, estimating flow, and assessing the presence of

thrombi. Cardiac catheterization gives a direct mea-

surement of transvalvular pressure gradient, from which

the area of the mitral annulus can be calculated.

33
Q

Mitral Stenosis: Therapy

A
  • Surgical options include valvulotomy or replacement.

Therapy is indicated for symptomatic patients.

34
Q

Mitral Regurgitation: Etiology

A
  • Approximately 40% of cases are caused by rheumatic

fever; other causes include idiopathic calcification

associated with hypertension, diabetes, AS, and renal

failure. Mitral valve prolapse progresses to MR in 5%

of affected individuals. Less common causes include

myocardial ischemia, trauma, endocarditis, and hyper-

trophic cardiomyopathy.

35
Q

Mitral Regurgitation: Pathophysiology

A
  • As regurgitation becomes hemodynamically significant,

the left ventricle dilates to preserve cardiac output. A

significant volume is ejected retrograde, increasing car-

diac work, left atrial volumes, and pulmonary venous

pressure. This, in turn, may lead to left atrial enlargement

and fibrillation or cause pulmonary hypertension, which

could result in right ventricular failure.

36
Q

Mitral Regurgitation: Epidemiology

A
  • MR is more common than MS and has a male pre-

dominance.

37
Q

Mitral Regurgitation: History

A
  • Patients commonly complain of dyspnea, orthopnea,

and fatigue.

38
Q

Mitral Regurgitation: Physical Examination

A
  • Patients may appear cachectic. Frequently, there is an

irregular pulse, pulmonary rales, and a sternal heave.

The pulse characteristically has a rapid upstroke, and

vwaves may be present. A holosystolic murmur that

radiates to the axilla or back is common. The point of

maximal impulse is often displaced.

39
Q

Mitral Regurgitation: Diagnostic Evaluation

A
  • Chest x-ray may show cardiomegaly and pulmonary
    edema. ECG commonly demonstrates left ventricular

or biventricular hypertrophy, left atrial enlargement,

and P mitrale. Echocardiography is extremely useful

in establishing the diagnosis and the underlying lesion.

Cardiac catheterization is useful in establishing pul-

monary pressures and cardiac output

40
Q

Mitral Regurgitation: Treatment

A
  • Medical therapy consists of afterload reducing agents,

such as angiotensin-converting enzyme inhibitors,

nitroglycerin, and diuretics. Surgical intervention is

indicated if congestive failure interferes with daily life,

if pulmonary hypertension or left ventricular dilation

worsens, or if atrial fibrillation develops. If life-threat-

ening MR develops from endocarditis, ischemia, or

trauma, aggressive treatment with afterload reduction,

a balloon pump if necessary, and antibiotics if indicated

should be used to convert an emergency operation to

an elective one. Because of the severe hemodynamic

instability that can occur, operative intervention

involving repair or replacement may be necessary in

the acute setting. These emergency operations carry greater than 15% mortality rate.

41
Q

Aortic Balloon Pumps and Ventricular Assist Devices

A
  • In patients with markedly decreased cardiac output

insufficient to sustain end organ perfusion, an intra-

aortic balloon pump may be useful to decrease after-

load, increase coronary perfusion, decrease myocardial

oxygen demand, and increase cardiac output (Figs. 17-5

and 17-6). These are temporary devices, generally placed

via a femoral approach. Correct placement is critical.

Occlusion of the left subclavian artery during infla-

tion must be avoided, and proximal location above

the renal arteries is also critical. Vascular complications,

including arterial thrombosis and embolism, must be

constantly checked for and may necessitate balloon

removal.

  • When medical therapy and intra-aortic balloon

pumps are insufficient to provide adequate cardiac out-

put, left ventricular assist devices may be used. These

are divided into pulsatile flow pumps and nonpulsatile

flow pumps, which use axial or centrifugal flow. These

pumps can be used in the short term, generally in

patients with temporary heart failure. These patients are

expected to improve, and a common indication is post-

cardiotomy syndrome. Left ventricular assist devices

can also be useful longer term as a bridge to transplan-

tation. Thromboembolism, bleeding, and infection are

common complications.

42
Q

Heart: Key Points

A
  • Coronary artery disease is the leading cause of mor-

tality in the United States.

  • Risk factors include hypertension, smoking, obesity,

diabetes, hypercholesterolemia, inactivity, and family

history.

  • Coronary artery disease is treated surgically if all

three coronary arteries or the left main coronary

artery are diseased or if patients have debilitating

symptoms.

  • Aortic stenosis can be caused by a congenital bicus-

pid valve or rheumatic fever; symptoms include

angina, syncope, and dyspnea.

  • Aortic insufficiency can be caused by rheumatic

fever, endocarditis, connective tissue disorders, aortic

dissection, and trauma; symptoms include angina

and dyspnea.

  • Mitral stenosis is most commonly caused by rheu-

matic fever; symptoms include fatigue and dyspnea.

  • Mitral regurgitation is caused by rheumatic fever,

idiopathic calcification, mitral valve prolapse, myocar-

dial ischemia, trauma, endocarditis, and hypertrophic

cardiomyopathy; symptoms include fatigue and

dyspnea.

  • Congenital heart disease can be broadly divided into lesions causing congestive heart failure or cyanosis.
  • Tetralogy of Fallot has four components: ventricular

septal defect, pulmonic stenosis, right ventricular

hypertrophy, and an overriding aorta.